ARTMS specializes in the physics, chemistry and materials science of cyclotron-produced radionuclides. Our core technology platform, the QUANTM Irradiation System™ (QIS™), is a complete cyclotron-based isotope production system designed to support high efficiency, large-scale and cost-effective production of commercially important medical isotopes such as zirconium-89 (89Zr), gallium-68 (68Ga), technetium‐99m (99mTc) and copper-64 (64Cu). QIS™ is used today by many of the major manufacturing networks to optimize production of a range of medical radioisotopes.
ARTMS has been acquired by Telix Pharmaceuticals.
Interested in joining the team? Search our open positions: https://telixpharma.com/careers/find-a-job/
Company Details
- Employees
- 29
- Founded
- -
- Address
- 8575 Commerce Crt, Burnaby,british Columbia V5a 4n5,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- artms.ca
- Keywords
- Radiopharmaceuticals, Technetium-99m, Cyclotron, Biomedical, Gallium-68, Copper-64, Zirconium-68, Nuclear Medicine, Oncology, Cardiology, Neurology, Medical Isotopes.
- HQ
- Burnaby, British Columbia
Artms Questions
Artms's website is artms.ca
Artms's LinkedIn profile is https://ca.linkedin.com/company/artms
Artms has
29 employees.
View email and phone details for 29
employees at Artms.
Artms's industry is
Pharmaceutical Manufacturing
Artms's top competitors are
Joku Inc.,
Telix Pharmaceuticals Limited,
Lantheus,
Nucleus Radiopharma,
Itm Isotope Technologies Munich Se,
Pharmalogic,
Clarity Pharmaceuticals,
Isotherapeutics,
Eckert & Ziegler Radiopharma Inc,
Triumf.
Artms's categories are Pharmaceutical Manufacturing
Artms's founding year is 2013
